Short pages
Jump to navigation
Jump to search
Showing below up to 50 results in range #17,711 to #17,760.
- (hist) Leukocytosis physical examination [368 bytes]
- (hist) Brugada syndrome cost-effectiveness of therapy [368 bytes]
- (hist) Brugada syndrome case study one [368 bytes]
- (hist) Acrocyanosis overview [368 bytes]
- (hist) Acrocyanosis classification [368 bytes]
- (hist) Volvulus medical therapy [368 bytes]
- (hist) Ogilvie syndrome other imaging findings [368 bytes]
- (hist) Hematemesis case study one [368 bytes]
- (hist) Hematemesis future or investigational therapies [368 bytes]
- (hist) Hematemesis cost-effectiveness of therapy [368 bytes]
- (hist) Neuroendocrine tumors primary prevention [368 bytes]
- (hist) Post transplant lymphoproliferative disorder differential diagnosis [368 bytes]
- (hist) Cryptogenic organizing pneumonia other imaging findings [368 bytes]
- (hist) Acute respiratory distress syndrome case study one [368 bytes]
- (hist) Barotrauma causes [368 bytes]
- (hist) Status asthmaticus secondary prevention [368 bytes]
- (hist) Interstitial nephritis other diagnostic studies [368 bytes]
- (hist) Interstitial nephritis cost-effectiveness of therapy [368 bytes]
- (hist) Interstitial nephritis future or investigational therapies [368 bytes]
- (hist) Interstitial nephritis case study one [368 bytes]
- (hist) Scrofula pathophysiology [368 bytes]
- (hist) Acute brachial neuritis CT [368 bytes]
- (hist) Creutzfeldt-Jakob disease case study one [368 bytes]
- (hist) Loa loa filariasis cost-effectiveness of therapy [368 bytes]
- (hist) Loa loa filariasis future or investigational therapies [368 bytes]
- (hist) Loa loa filariasis case study one [368 bytes]
- (hist) Creutzfeldt-Jakob disease cost-effectiveness of therapy [368 bytes]
- (hist) Loa loa filariasis differential diagnosis [368 bytes]
- (hist) Loa loa filariasis natural history, complications and prognosis [368 bytes]
- (hist) Brugada syndrome future or investigational therapies [368 bytes]
- (hist) Second degree AV block cost-effectiveness of therapy [368 bytes]
- (hist) Second degree AV block future or investigational therapies [368 bytes]
- (hist) Second degree AV block case study one [368 bytes]
- (hist) Encopresis historical perspective [368 bytes]
- (hist) Encopresis classification [368 bytes]
- (hist) Encopresis laboratory findings [368 bytes]
- (hist) Encopresis CT [368 bytes]
- (hist) Encopresis MRI [368 bytes]
- (hist) Encopresis ultrasound [368 bytes]
- (hist) Encopresis other imaging findings [368 bytes]
- (hist) Encopresis other diagnostic studies [368 bytes]
- (hist) Encopresis surgery [368 bytes]
- (hist) Encopresis secondary prevention [368 bytes]
- (hist) Encopresis cost-effectiveness of therapy [368 bytes]
- (hist) Encopresis future or investigational therapies [368 bytes]
- (hist) Encopresis case study one [368 bytes]
- (hist) Cefamandole drug interactions [368 bytes]
- (hist) Myasthenia gravis other imaging findings [368 bytes]
- (hist) Polymyalgia rheumatica surgery [368 bytes]
- (hist) Vitamin D deficiency surgery [368 bytes]